NCT04221659

Brief Summary

Parkinson's disease (PD) is a neurodegenerative and progressive movement disorder, whose population incidence is increasing. It is characterized by motor symptoms such as tremor, stiffness and bradykinesia, and non-motor symptoms, highlighting the executive dysfunction that can be present from the early stages of the disease. These deficits increase the risk of falls and reduce functional independence. Transcranial Direct Current Stimulation (ETCC) can be an attractive rehabilitation option in PD because it is a non-invasive and safe method that can modulate cortical excitability and improve motor and non-motor symptoms. One of the techniques to detect neurophysiological biomarkers associated with changes in the functional health of the brain and the effectiveness of this type of treatment is the analysis of microstates from the electroencephalogram (EEG). So, the objective of the present study is to investigate the effects of different assemblies of multifocal ETCC on the electrical brain activity represented by the EEG microstates and clinical characteristics in patients with PD.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Dec 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2019

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

January 6, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 9, 2020

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2021

Completed
Last Updated

May 4, 2020

Status Verified

April 1, 2020

Enrollment Period

11 months

First QC Date

January 6, 2020

Last Update Submit

April 30, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in EEG microstates

    For the analysis of the EEG microstates the following temporal parameters will be considered: the average duration of each microstate; its frequency of occurrence; the fraction of the total recording time covered by each; the overall variation explained by each microstate and the probabilities of transition from one microstate to another. The brain electrical activity will be acquired through the BrainVision actiCHamp equipment using 32 Ag / AgCl electrodes that will be fixed according to the International 10-20 System, keeping the impedance below 10kΩ in silent condition and in eyes open states. and eyes closed. The output of the amplifier data will be directed to a computer with BrainVision Pycoder software to record the obtained records and the data will be processed using the BrainVision Analyzer.

    Baseline, after 6 weeks, and after 10 weeks

Secondary Outcomes (5)

  • Spectral analysis of EEG frequencies

    Baseline, after 6 weeks, and after 10 weeks

  • Motor aspects of daily life

    Baseline, after 6 weeks, and after 10 weeks

  • Stroop test

    Baseline, after 6 weeks, and after 10 weeks

  • Dual Task

    Baseline, after 6 weeks, and after 10 weeks

  • Verbal Fluency Test

    Baseline, after 6 weeks, and after 10 weeks

Study Arms (3)

tDCS over M1 and DLPFC

EXPERIMENTAL

Anodic transcranial direct current stimulation (tDCS) over right primary motor cortex (M1) and left dorsolateral prefrontal cortex (DLPFC). Duration: 20 minutes; Intensity: 2mA.

Device: Transcranial Direct Current Stimulation

tDCS over M1 and FPA

EXPERIMENTAL

Anodic transcranial direct current stimulation (tDCS) over right primary motor cortex (M1) and left frontal polar area (FPA). Duration: 20 minutes; Intensity: 2mA.

Device: Transcranial Direct Current Stimulation

tDCS over M1

ACTIVE COMPARATOR

Anodic transcranial direct current stimulation (tDCS) over right primary motor cortex (M1). Duration: 20 minutes; Intensity: 2mA.

Device: Transcranial Direct Current Stimulation

Interventions

Participants will receive 16 sessions of Transcranial Direct Current Stimulation (tDCS) for 20 minutes each at 2 mA intensity, on alternate days (3 times a week). The current will be delivered via saline-embedded sponge surface electrodes using a battery-powered neurostimulator (TCT-Research, Trans Cranial Technologies, Hong Kong). A small active specific electrode (5x5 cm) will be used to prevent coverage of adjacent areas, resulting in a current density of 0.08 mA / cm². The cathode, reference electrode (5x7cm), will be positioned in the occipital region. These parameters are within the safe limits established in previous human studies.

tDCS over M1tDCS over M1 and DLPFCtDCS over M1 and FPA

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic PD, issued by a neurologist specializing in movement disorders;
  • Disease staging between I and III, according to the modified Hoehn and Yahr scale;
  • Regular antiparkinsonian pharmacological treatment;
  • Score higher than 24 or 18 (for participants with low education) in the Mini -Mental State Examination
  • Ages: 40 - 75 years
  • Sex: All
  • Subjects who do not have self-report of neurodegenerative disorders

You may not qualify if:

  • Diagnosis of atypical parkinsonism;
  • Neurological comorbidities;
  • History of epilepsy, neurosurgery (including metal clip implantation) and pacemaker implantation;
  • DBS implantation - deep brain stimulation;
  • Patients missing two consecutive protocol sessions.
  • History of epilepsy;
  • Metallic implants in the head;
  • Clinical evidence of brain injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Suellen Marinho Andrade

João Pessoa, Paraíba, Brazil

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Suellen Andrade

    Federal University of Paraiba

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator and Teacher

Study Record Dates

First Submitted

January 6, 2020

First Posted

January 9, 2020

Study Start

December 1, 2019

Primary Completion

November 1, 2020

Study Completion

January 1, 2021

Last Updated

May 4, 2020

Record last verified: 2020-04

Locations